Therapeutic effects of guggul and its constituent guggulsterone: Cardiovascular benefits

152Citations
Citations of this article
156Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Oleogum resin (known as guggul) from the guggul tree, Commiphora mukul, found in India, Bangladesh, and Pakistan, has been used to treat various diseases including hyper-cholesterolemia, atherosclerosis, rheumatism, and obesity over several thousands of years. Guggulsterone isolated from guggul has been identified as the bioactive constituent responsible for guggul's therapeutic effects. Since the first study demonstrating the therapeutic effects of guggul in an animal model in 1966, numerous preclinical and clinical trails have been carried out. Although differences in study design, methodological quality, statistical analysis, sample size, and subject population result in certain inconsistencies in the response to therapy, the cumulative data from in vitro, preclinical, and clinical studies largely support the therapeutic claims for guggul described in the ancient Ayurvedic text. However, future clinical studies with much larger size and longer term are required to confirm these claims. The cardiovascular benefits of the therapy are derived from the multiple pharmacological activities associated with guggul or guggulsterone, notably its hypolipidemic, antioxidant, and antiinflammatory activities. It has been established that guggulsterone is an antagonist at farnesoid x receptor (FXR), a key transcriptional regulator for the maintenance of cholesterol and bile acid homeostasis. The FXR antagonism by guggulsterone has been proposed as a mechanism for its hypolipidemic effect. A recent study demonstrates that guggulsterone upregulates the bile salt export pump (BSEP), an efflux transporter responsible for removal of cholesterol metabolites, bile acids from the liver. Such upregulation of BSEP expression by guggulsterone favors cholesterol metabolism into bile acids, and thus represents another possible mechanism for its hypolipidemic activity. Guggulsterone has been found to potently inhibit the activation of nuclear factor-κB (NF-κB), a critical regulator of inflammatory responses. Such repression of NF-κB activation by guggulsterone has been proposed as a mechanism of the antiinflammatory effect of guggulsterone. © 2007 The Authors.

References Powered by Scopus

Atherosclerosis

5082Citations
N/AReaders
Get full text

Atherosclerosis: The road ahead

2783Citations
N/AReaders
Get full text

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1670Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Role of bile acids and bile acid receptors in metabolic regulation

1354Citations
N/AReaders
Get full text

Identification of novel anti-inflammatory agents from ayurvedic medicine for prevention of chronic diseases: "Reverse pharmacology" and "Bedside to bench" approach

258Citations
N/AReaders
Get full text

Medicinal plants, human health and biodiversity: A broad review

245Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Deng, R. (2007, December). Therapeutic effects of guggul and its constituent guggulsterone: Cardiovascular benefits. Cardiovascular Drug Reviews. https://doi.org/10.1111/j.1527-3466.2007.00023.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 47

54%

Researcher 29

33%

Professor / Associate Prof. 7

8%

Lecturer / Post doc 4

5%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 26

34%

Biochemistry, Genetics and Molecular Bi... 20

26%

Medicine and Dentistry 19

25%

Pharmacology, Toxicology and Pharmaceut... 11

14%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free